Data & AI for Healthcare & Pharmaceuticals

Transforming and creating value for pharmaceuticals, hospitals, clinicals, telemedicine, biotechnologies through the power of data & AI.

The global AI in healthcare market was valued at $19.54 billion in 2023 and is projected to reach $490.96 billion by 2032, with a CAGR of 43.2% (Grand View Research) (Fortune Business Insights).

Operational Efficiency: AI improves data analysis, with machine learning helping to structure 97% of previously unused healthcare data. (Healthtech Solutions).
Medical Imaging and Diagnostics: AI tools enhance diagnostic accuracy and reduce interpretation times for medical images, aiding in early disease detection. (Healthtech Solutions) (Grand View Research).

Drug Discovery and Development: AI reduces drug discovery times from 5-6 years to just one year, significantly speeding up the process. (Grand View Research).
Personalized Medicine: AI analyzes genomic and medical data to develop personalized treatment plans, improving treatment efficacy. (Fortune Business Insights).

SANOFI CHC Precision Marketing – Industrialising the deployment of data-driven...

PIERRE FABRE GROUP Accelerating online growth with a global e-Retail...

The Carnot CALYM Institute Fighting against lymphoma with Artificial Intelligence

SANOFI CHC Driving Digital Transformation With Precision Marketing‌‌

PIERRE FABRE COSMÉTIQUES Using Precision Marketing to change the customer...

November 21th, 2024
Station F, Paris

Unleashing the power of AI in Clinical Trials: Key Insights from PFIZER and ARTEFACT – AI for Health Summit
Read more
SANOFI, AWS, IKTOS, ELAIA and MIND GROUP at AI for Health – The generative AI revolution for drug discovery
Read more
ROCHE, PULSELIFE and SALESFORCE at the AI for Health Summit – Omni-channel engagement of HCPs in the Age of GenAI
Read more
PFIZER at the AI for Health Summit – AI: On a mission to make drug development faster and smarter
Read more